TY - JOUR
T1 - PET/MR Imaging in Evaluating Treatment Failure of Head and Neck Malignancies
T2 - A Neck Imaging Reporting and Data System–Based Study
AU - Patel, L. D.
AU - Bridgham, K.
AU - Ciriello, J.
AU - Almardawi, R.
AU - Leon, J.
AU - Hostetter, J.
AU - Yazbek, S.
AU - Raghavan, P.
N1 - Publisher Copyright:
Copyright 2022 by American Society of Neuroradiology.
PY - 2022/3/1
Y1 - 2022/3/1
N2 - BACKGROUND AND PURPOSE: PET/MR imaging is a relatively new hybrid technology that holds great promise for the evaluation of head and neck cancer. The aim of this study was to assess the performance of simultaneous PET/MR imaging versus MR imaging in the evaluation of posttreatment head and neck malignancies, as determined by its ability to predict locoregional recurrence or progression after imaging. MATERIALS AND METHODS: The electronic medical records of patients who had posttreatment PET/MR imaging studies were reviewed, and after applying the exclusion criteria, we retrospectively included 46 studies. PET/MR imaging studies were independently reviewed by 2 neuroradiologists, who recorded scores based on the Neck Imaging Reporting and Data System (using CT/PET-CT criteria) for the diagnostic MR imaging sequences alone and the combined PET/MR imaging. Treatment failure was determined with either biopsy pathology or initiation of new treatment. Statistical analyses including univariate association, interobserver agreement, and receiver operating characteristic analysis were performed. RESULTS: There was substantial interreader agreement among PET/MR imaging scores (k ¼ 0.634; 95% CI, 0.605–0.663). PET/MR imaging scores showed a strong association with treatment failure by univariate association analysis, with P, .001 for the primary site, neck lymph nodes, and combined sites. Receiver operating characteristic curves of PET/MR imaging scores versus treatment failure indicated statistically significant diagnostic accuracy (area under curve range, 0.864–0.987; P, .001). CONCLUSIONS: Simultaneous PET/MR imaging has excellent discriminatory performance for treatment outcomes of head and neck malignancy when the Neck Imaging Reporting and Data System is applied. PET/MR imaging could play an important role in surveillance imaging for head and neck cancer.
AB - BACKGROUND AND PURPOSE: PET/MR imaging is a relatively new hybrid technology that holds great promise for the evaluation of head and neck cancer. The aim of this study was to assess the performance of simultaneous PET/MR imaging versus MR imaging in the evaluation of posttreatment head and neck malignancies, as determined by its ability to predict locoregional recurrence or progression after imaging. MATERIALS AND METHODS: The electronic medical records of patients who had posttreatment PET/MR imaging studies were reviewed, and after applying the exclusion criteria, we retrospectively included 46 studies. PET/MR imaging studies were independently reviewed by 2 neuroradiologists, who recorded scores based on the Neck Imaging Reporting and Data System (using CT/PET-CT criteria) for the diagnostic MR imaging sequences alone and the combined PET/MR imaging. Treatment failure was determined with either biopsy pathology or initiation of new treatment. Statistical analyses including univariate association, interobserver agreement, and receiver operating characteristic analysis were performed. RESULTS: There was substantial interreader agreement among PET/MR imaging scores (k ¼ 0.634; 95% CI, 0.605–0.663). PET/MR imaging scores showed a strong association with treatment failure by univariate association analysis, with P, .001 for the primary site, neck lymph nodes, and combined sites. Receiver operating characteristic curves of PET/MR imaging scores versus treatment failure indicated statistically significant diagnostic accuracy (area under curve range, 0.864–0.987; P, .001). CONCLUSIONS: Simultaneous PET/MR imaging has excellent discriminatory performance for treatment outcomes of head and neck malignancy when the Neck Imaging Reporting and Data System is applied. PET/MR imaging could play an important role in surveillance imaging for head and neck cancer.
UR - http://www.scopus.com/inward/record.url?scp=85126384576&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126384576&partnerID=8YFLogxK
U2 - 10.3174/ajnr.A7427
DO - 10.3174/ajnr.A7427
M3 - Article
C2 - 35177543
AN - SCOPUS:85126384576
SN - 0195-6108
VL - 43
SP - 435
EP - 441
JO - American Journal of Neuroradiology
JF - American Journal of Neuroradiology
IS - 3
ER -